Equities

ICU Medical Inc

ICU Medical Inc

Actions
  • Price (EUR)165.00
  • Today's Change-2.00 / -1.20%
  • Shares traded2.00
  • 1 Year change+117.11%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 07:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments255213567
Total Receivables, Net164225110
Total Inventory709696290
Prepaid expenses515741
Other current assets, total424422
Total current assets1,2211,2351,030
Property, plant & equipment, net686714508
Goodwill, net1,4721,44943
Intangibles, net871983188
Long term investments3.123.694.62
Note receivable - long term------
Other long term assets8810064
Total assets4,3784,5161,881
LIABILITIES
Accounts payable15021681
Accrued expenses236211105
Notes payable/short-term debt000
Current portion long-term debt/capital leases52310.64
Other current liabilities, total443714
Total current liabilities482495201
Total long term debt1,5801,6262.07
Total debt1,6321,6562.71
Deferred income tax561261.49
Minority interest------
Other liabilities, total13818060
Total liabilities2,2552,426265
SHAREHOLDERS EQUITY
Common stock2.412.402.13
Additional paid-in capital1,3661,331721
Retained earnings (accumulated deficit)808838912
Treasury stock - common(0.26)(0.24)(0.03)
Unrealized gain (loss)2241(0.24)
Other equity, total(75)(122)(19)
Total equity2,1232,0901,616
Total liabilities & shareholders' equity4,3784,5161,881
Total common shares outstanding242421
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.